← Browse by Condition
Medical Condition

infertility female

Total Trials
5
Recruiting Now
5
Trial Phases
Phase 4

ClinicalMetric tracks all active clinical trials for infertility female sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — infertility female Clinical Trials

How many clinical trials are currently recruiting for infertility female?
ClinicalMetric currently tracks 5 actively recruiting clinical trials for infertility female, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 5. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for infertility female?
infertility female research spans Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a infertility female clinical trial?
Eligibility criteria for infertility female trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 4
1
Top Sponsors
University of Southern California 1 trial
ART Fertility Clinics LLC 1 trial
Nanjing University 1 trial
Semmelweis University 1 trial
University Hospital, Geneva 1 trial

Recruiting Clinical Trials

NCT06701071 Phase 4
Recruiting
Evaluation of a Long Versus Short Clomid Protocol for Controlled Ovarian Stimulation
Enrollment
120 pts
Location
United States
Sponsor
University of Southern Califor...
View Trial →
NCT05473273
Recruiting
Descriptive Analysis of Serum Immunological Markers During an Euploid Frozen Embryo Transfer in a Natural Cycle.
Enrollment
40 pts
Location
United Arab Emirates
Sponsor
ART Fertility Clinics LLC
View Trial →
NCT07128394
Recruiting
Extra Luteinizing Hormone Improve Embryo Quality in IVF Patients With Low LH During Long GnRH-Agonist Treatment
Enrollment
590 pts
Location
China
Sponsor
Nanjing University
View Trial →
NCT06167135
Recruiting
Polycystic Ovary Syndrome, Mitochondrial Dysfunction, Obesity, Insulin Resistance Infertility (POMODORI) Cohort
Enrollment
150 pts
Location
Hungary
Sponsor
Semmelweis University
View Trial →
NCT04419740
Recruiting
Impact of a Mindfulness Intervention on Infertile Women Undergoing Assisted Reproductive Technique Treatments
Enrollment
150 pts
Location
Switzerland
Sponsor
University Hospital, Geneva
View Trial →

Related Conditions

luteinizing hormone lh (1) polycystic ovary syndrome (1) insulin resistance (1) primary ovarian insufficiency (1) mitochondrial alteration (1) obesity (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology